ストックスクリーナーアプリを入手
244.55
0.71%
1.72
アフターアワーズ：
244.54
-0.01
-0.00%
前日終値:
$242.83
開ける：
$242.22
24時間の取引高:
1.37M
Relative Volume:
1.05
時価総額：
$33.75B
収益：
$1.96B
当期純損益:
$-253.24M
株価収益率:
-128.63
EPS:
-1.9012
ネットキャッシュフロー:
$94.06M
1週間 パフォーマンス:
+2.40%
1か月 パフォーマンス:
+22.32%
6か月 パフォーマンス:
+47.76%
1年 パフォーマンス:
+44.69%
1日の値動き範囲:
$239.00
$245.59
1週間の範囲:
$233.67
$245.59
52週間の値動き範囲:
$125.38
$245.59
Natera Inc Stock (NTRA) Company Profile
NTRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
244.55 | 33.41B | 1.96B | -253.24M | 94.06M | -1.9012 |
|
TMO
Thermo Fisher Scientific Inc
|
572.77 | 216.12B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.25 | 160.43B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
714.10 | 57.29B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
145.49 | 41.98B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
225.85 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-02 | 再開されました | Morgan Stanley | Overweight |
| 2025-10-27 | アップグレード | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | 再開されました | Wells Fargo | Equal Weight |
| 2025-03-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-01-23 | 開始されました | Barclays | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-08 | 再開されました | Craig Hallum | Buy |
| 2024-02-20 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | 繰り返されました | BTIG Research | Buy |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-11-13 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | 開始されました | Bernstein | Mkt Perform |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-05 | 開始されました | UBS | Buy |
| 2023-01-18 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-04-25 | 開始されました | Stephens | Overweight |
| 2022-03-08 | 開始されました | Goldman | Buy |
| 2022-01-06 | 再開されました | Piper Sandler | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-15 | 開始されました | Raymond James | Mkt Perform |
| 2021-05-25 | 開始されました | Wells Fargo | Overweight |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-10-08 | 開始されました | BTIG Research | Buy |
| 2020-09-28 | 開始されました | Morgan Stanley | Overweight |
| 2020-09-17 | 開始されました | SVB Leerink | Outperform |
| 2020-06-10 | 再開されました | Piper Sandler | Overweight |
| 2020-05-07 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-10-05 | 開始されました | JP Morgan | Neutral |
| 2018-07-05 | 繰り返されました | Piper Jaffray | Overweight |
| 2017-08-07 | 繰り返されました | Morgan Stanley | Overweight |
| 2016-11-10 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-23 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-11 | 繰り返されました | The Benchmark Company | Buy |
| 2016-04-19 | 開始されました | The Benchmark Company | Buy |
| 2015-09-28 | アップグレード | Wedbush | Neutral → Outperform |
| 2015-08-14 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | 開始されました | Robert W. Baird | Outperform |
| 2015-07-27 | 開始されました | Morgan Stanley | Equal-Weight |
| 2015-07-27 | 開始されました | Piper Jaffray | Overweight |
| 2015-07-27 | 開始されました | Wedbush | Neutral |
すべてを表示
Natera Inc (NTRA) 最新ニュース
Natera acquires Foresight Diagnostics to expand cancer detection capabilities By Investing.com - Investing.com Nigeria
Should Natera’s (NTRA) New Share Offering and Signatera Lymphoma Data Require Action From Investors? - simplywall.st
Dir Chapman Files To Sell 4,366 Of Natera Inc [NTRA] - TradingView
Natera envisions cancer-testing future with $450M Foresight buy - BioWorld MedTech
Boulder diagnostics co. bought by Austin biotech giant in $450M deal - The Business Journals
Why Is Adaptive Biotechnologies Stock Trading Lower After Natera's Over $400 Million Deal? - Benzinga
Working capital per share of Natera, Inc. – DUS:45E - TradingView
Natera buys Foresight Diagnostics in $450M cancer testing deal - Fierce Biotech
Austin biotech giant Natera acquires Colorado diagnostics company - The Business Journals
Natera (NASDAQ:NTRA) Hits New 1-Year HighWhat's Next? - MarketBeat
Natera Acquires Foresight Diagnostics - Contract Pharma
ETFs Investing in Natera, Inc. Stocks - TradingView
Natera Acquires Foresight Diagnostics for $275 Million - TipRanks
Natera Completes Foresight Diagnostics Acquisition in All-Stock Deal - marketscreener.com
Natera acquires Foresight Diagnostics - marketscreener.com
Steven Leonard Chapman Sells 4,400 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Solomon Moshkevich Sells 3,000 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera, Inc. Earnings and Revenue – GETTEX:45E - TradingView
Net income of Natera, Inc. – GETTEX:45E - TradingView
Natera (NTRA): Assessing Valuation After a Powerful Multi‑Month Share Price Rally - Yahoo Finance
Natera stock reaches all-time high of 241.36 USD - Investing.com
Natera stock reaches all-time high of 241.36 USD By Investing.com - Investing.com Canada
Natera Inc: President Moshkevich sells $714k in stock By Investing.com - Investing.com South Africa
New York State Common Retirement Fund Raises Holdings in Natera, Inc. $NTRA - MarketBeat
XTX Topco Ltd Sells 34,439 Shares of Natera, Inc. $NTRA - MarketBeat
A Look At The Intrinsic Value Of Natera, Inc. (NASDAQ:NTRA) - Yahoo Finance
Edgestream Partners L.P. Grows Stock Position in Natera, Inc. $NTRA - MarketBeat
Arrowstreet Capital Limited Partnership Raises Position in Natera, Inc. $NTRA - MarketBeat
Insider Sell: Solomon Moshkevich Sells 3,000 Shares of Natera In - GuruFocus
Natera Inc: President Moshkevich sells $714k in stock - Investing.com
Natera CEO Chapman sells $1.05 million in stock - Investing.com
Natera CEO Chapman sells $1.05 million in stock By Investing.com - Investing.com UK
Officer Moshkevich Sells 3,000 ($714.5K) Of Natera Inc [NTRA] - TradingView
Natera, Inc.: Revenue and Earnings Analysts Forecasts Revisions | 45E | US6323071042 - marketscreener.com
Natera, Inc.: Dividend historical data and projections - marketscreener.com
Natera (NTRA): Valuation Check After ASH Signatera Lymphoma Data Fuels Hematology Growth Optimism - simplywall.st
NTRA: Double-digit MRD growth, broad Signatera adoption, and new clinical data drive future expansion - TradingView
Natera (NASDAQ: NTRA) to Present 144-Patient Lymphoma Signatera Data at ASH 2025 - Stock Titan
Panagora Asset Management Inc. Grows Stake in Natera, Inc. $NTRA - MarketBeat
Schroder Investment Management Group Reduces Stock Position in Natera, Inc. $NTRA - MarketBeat
Russell Investments Group Ltd. Lowers Position in Natera, Inc. $NTRA - MarketBeat
Hsbc Holdings PLC Trims Stock Position in Natera, Inc. $NTRA - MarketBeat
Morgan Stanley Raises Natera (NTRA) Price Target with Overweight Rating | NTRA Stock News - GuruFocus
Morgan Stanley assumes coverage on Natera stock with Overweight rating By Investing.com - Investing.com Nigeria
Natera to Present 12 Datasets Including >50,000 Patients Featuring Signatera™ at the San Antonio Breast Cancer Symposium - Yahoo Finance
Pura Vida Investments LLC Boosts Stock Holdings in Natera, Inc. $NTRA - MarketBeat
Morgan Stanley Raises Price Target on Natera to $265 From $220, Keeps Overweight Rating - marketscreener.com
Norges Bank Invests $277.75 Million in Natera, Inc. $NTRA - MarketBeat
Korea Investment CORP Boosts Stake in Natera, Inc. $NTRA - MarketBeat
State Board of Administration of Florida Retirement System Buys 4,864 Shares of Natera, Inc. $NTRA - MarketBeat
Morgan Stanley Maintains Natera (NTRA) Overweight Recommendation - MSN
Natera Inc (NTRA) 財務データ
収益
当期純利益
現金流量
EPS
0.41%
0.56%
大文字化:
|
ボリューム (24 時間):